Cargando…

A new prediction model integrated serum lipid profile for patients with multiple myeloma

Purpose: This study aimed to explore a predictive risk-stratification model combing clinical characteristics and lipid profiles in multiple myeloma (MM) patients. Methods: The data of 275 patients in Sun Yat-Sen University Cancer Center were retrospectively analyzed and randomly divided into the tra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Huizhong, Chen, Biyun, Shao, Ruonan, Liu, Wenjian, Xiong, Lang, Li, Li, Lu, Yue
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8990419/ https://www.ncbi.nlm.nih.gov/pubmed/35399725 http://dx.doi.org/10.7150/jca.69321

Ejemplares similares

Integrative analysis identifies CXCL11 as an immune-related prognostic biomarker correlated with cell proliferation and immune infiltration in multiple myeloma microenvironment
por: Wang, Huizhong, et al.
Publicado: (2022)

Integrative Analysis of a Pyroptosis-Related Signature of Clinical and Biological Value in Multiple Myeloma
por: Wang, Huizhong, et al.
Publicado: (2022)

Integrated assessment of the clinical and biological value of ferroptosis-related genes in multiple myeloma
por: Fu, Bibo, et al.
Publicado: (2022)

Establishment of a prognostic ferroptosis‐related gene profile in acute myeloid leukaemia
por: Shao, Ruonan, et al.
Publicado: (2021)

Lipid profile as a novel prognostic predictor for patients with acute myeloid leukemia
por: Bai, Shenrui, et al.
Publicado: (2023)

Identification of a prognostic metabolic gene signature in diffuse large B‐cell lymphoma
por: Wang, Huizhong, et al.
Publicado: (2021)

High level of interleukin-10 in serum predicts poor prognosis in multiple myeloma
por: Wang, Hua, et al.
Publicado: (2016)

Lipid metabolic vulnerabilities of multiple myeloma
por: Torcasio, Roberta, et al.
Publicado: (2023)

Integrated analysis of serum lipid profile for predicting clinical outcomes of patients with malignant biliary tumor
por: Sun, Lejia, et al.
Publicado: (2020)

Exosome miRNAs profiling in serum and prognostic evaluation in patients with multiple myeloma
por: Fang, Teng, et al.
Publicado: (2023)

Cladribine with Granulocyte Colony‐Stimulating Factor, Cytarabine, and Aclarubicin Regimen in Refractory/Relapsed Acute Myeloid Leukemia: A Phase II Multicenter Study
por: Wang, Hua, et al.
Publicado: (2020)

Vitamin D deficiency linked to abnormal bone and lipid metabolism predicts high-risk multiple myeloma with poorer prognosis
por: Bao, Li, et al.
Publicado: (2023)

Predictive Role of Immune Profiling for Survival of Multiple Myeloma Patients
por: Zhaoyun, Liu, et al.
Publicado: (2021)

Drug Inhibition Profile Prediction for NFκB Pathway in Multiple Myeloma
por: Peng, Huiming, et al.
Publicado: (2011)

Gene Expression Profile Alone Is Inadequate In Predicting Complete Response In Multiple Myeloma
por: Amin, Samirkumar B., et al.
Publicado: (2014)

Evidence for ABL Amplification in Multiple Myeloma and Therapeutic Implications
por: Huang, He, et al.
Publicado: (2022)

P838: EXOSOME MIRNAS PROFILING IN SERUM AND PROGNOSTIC EVALUATION IN PATIENTS WITH MULTIPLE MYELOMA
por: Fang, Teng, et al.
Publicado: (2023)

High serum lactate dehydrogenase predicts an unfavorable outcome in Chinese elderly patients with multiple myeloma
por: Gu, Yan, et al.
Publicado: (2017)

Serum levels of soluble programmed death ligand 1 predict treatment response and progression free survival in multiple myeloma
por: Wang, Liang, et al.
Publicado: (2015)

Serum lipid profiles are associated with disability and MRI outcomes in multiple sclerosis
por: Weinstock-Guttman, Bianca, et al.
Publicado: (2011)

Identification of key biomarkers associated with cell adhesion in multiple myeloma by integrated bioinformatics analysis
por: Peng, Yue, et al.
Publicado: (2020)

Monitoring multiple myeloma by quantification of recurrent mutations in serum
por: Rustad, Even Holth, et al.
Publicado: (2017)

Integrated safety profile of selinexor in multiple myeloma: experience from 437 patients enrolled in clinical trials
por: Gavriatopoulou, Maria, et al.
Publicado: (2020)

Serum B-cell maturation antigen: a novel biomarker to predict outcomes for multiple myeloma patients
por: Ghermezi, Michael, et al.
Publicado: (2017)

Serum lipid profiles and aggressive prostate cancer
por: Li, Yanjing, et al.
Publicado: (2015)

Serum Parathyroid Hormone Is a New Potential Risk Factor in Multiple Myeloma
por: Kang, Min-Gu, et al.
Publicado: (2014)

Serum hsa_circ_0087776 as a new oncologic marker for the joint diagnosis of multiple myeloma
por: Gong, Xingxing, et al.
Publicado: (2021)

Analysis of Serum IgG1 to Predict Progression and Therapeutic Effect in Patients with Multiple Myeloma
por: Yin, Jingping, et al.
Publicado: (2022)

Heterogeneity of genomic evolution and mutational profiles in multiple myeloma
por: Bolli, Niccolo, et al.
Publicado: (2014)

Kinome expression profiling to target new therapeutic avenues in multiple myeloma
por: de Boussac, Hugues, et al.
Publicado: (2020)

Predicting Risk of Infection in Patients with Newly Diagnosed Multiple Myeloma: Utility of Immune Profiling
por: Teh, Benjamin W., et al.
Publicado: (2017)

Mutational analysis and protein profiling predict drug sensitivity in multiple myeloma cell lines
por: Giliberto, Mariaserena, et al.
Publicado: (2022)

Predicting ultrahigh risk multiple myeloma by molecular profiling: an analysis of newly diagnosed transplant eligible myeloma XI trial patients
por: Shah, Vallari, et al.
Publicado: (2020)

Serum Lipid Profiles, Lipid Ratios and Chronic Kidney Disease in a Chinese Population
por: Zhang, Liying, et al.
Publicado: (2014)

Analysis of the Metabolic Characteristics of Serum Samples in Patients With Multiple Myeloma
por: Du, Haiwei, et al.
Publicado: (2018)

Clinical impact of serum soluble SLAMF7 in multiple myeloma
por: Ishibashi, Mariko, et al.
Publicado: (2018)

Profile of elotuzumab and its potential in the treatment of multiple myeloma
por: Liu, Yi-Chang, et al.
Publicado: (2014)

Expression profile of telomere-associated genes in multiple myeloma
por: de la Guardia, Rafael Díaz, et al.
Publicado: (2012)

Serum Abnormal Metabolites for Evaluating Therapeutic Response and Prognosis of Patients With Multiple Myeloma
por: Wei, Yujun, et al.
Publicado: (2022)

Multiple myeloma-derived exosomes inhibit osteoblastic differentiation and improve IL-6 secretion of BMSCs from multiple myeloma
por: Liu, Zhaoyun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_phnrlup67pl7m9di7bkllfd5e8